The global extracorporeal membrane oxygenation machine market is experiencing growth due to rise in the incidence of chronic diseases especially cardiac disease, and increase in focus of the key players toward innovative extracorporeal membrane oxygenation machine technologies.
WILMINGTON, Del., Feb. 23, 2026 /PRNewswire/ -- Allied Market Research published a report, titled, "Extracorporeal Membrane Oxygenation Machine (ECMO) Market by Type (Veno-arterial, Veno-venous and Others), Components (Pumps, Oxygenator, Controllers and Others), and Application (Adult, Pediatric and Neonates): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the extracorporeal membrane oxygenation machine (ECMO) market was valued at $504.2 million in 2023, and is estimated to reach $793.7 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033.
Request Sample of the Report on Extracorporeal Membrane Oxygenation Machine (ECMO) Market Forecast 2033 -
https://www.alliedmarketresearch.com/request-sample/A284556
The global extracorporeal membrane oxygenation machine market is experiencing growth due to increase in the prevalence of severe respiratory diseases, including pneumonia, chronic obstructive pulmonary disease, and acute respiratory distress syndrome. Modern life support systems have become essential due to the rise in incidence of heart failure, myocardial infarction, and other cardiovascular diseases. In addition, there are constant advancements in extracorporeal membrane oxygenation technology. Furthermore, development of portable and compact extracorporeal membrane oxygenation machines that can be used in various settings, including during patient transport and in field hospitals are driving the market growth.
Report coverage & details:
Report Coverage | Details |
Forecast Period | 2024-2033 |
Base Year | 2023 |
Market Size in 2023 | $504.23 million |
Market Size in 2033 | $793.60 million |
CAGR | 4.1 % |
No. of Pages in Report | 280 |
Segments Covered | Type, Component, Application, and Region. |
Drivers | Increasing prevalence of cardiovascular and respiratory diseases. |
Technological advancements in ECMO | |
Growth in demand for extracorporeal membrane oxygenation (ECMO) in lung transplants. | |
Opportunities | Opportunities in developing economies |
Restraint | High cost of ECMO procedures |
Increase in utilization of oxygenators
The oxygenator is a crucial component of extracorporeal membrane oxygenation machine serves as an artificial lung to facilitate gas exchange. Advancements in design have resulted in small and portable oxygenators, facilitating easier transport of extracorporeal membrane oxygenation patients within and between healthcare facilities without interrupting life support.
Rise in adoption of Arterio-Venous machine
Arterio-venous extracorporeal membrane oxygenation machines provide several advantages in critical care, especially for patients with severe cardiac and respiratory failure. Arterio-venous extracorporeal membrane oxygenation machines are simpler to implement than other types because it does not require cannulation of a major vein and artery. It might be less invasive since other types involve arterial cannulation, which can be technically challenging and carries higher risks of complications like limb ischemia.
Adult segment to dominate the market in 2033
The demand for extracorporeal membrane oxygenation machine is expected to experience growth as adults are anticipated to suffer from severe respiratory conditions. In addition, the prevalence of heart failure, myocardial infarction, and other cardiovascular diseases is higher in the adult population, driving the demand for extracorporeal membrane oxygenation machines as a life-saving intervention. The aging global population, which is susceptible to severe cardiopulmonary conditions, significantly contributes to the demand for extracorporeal membrane oxygenation machines in the adult segment.
How Intense Is Market Competition and What Defines Competitive Advantage?
Competition in the extracorporeal membrane oxygenation machine market is moderate to high. Leading companies such as Medtronic plc, Getinge AB, Terumo Corporation, LivaNova PLC, and Fresenius Medical Care collectively dominate the market. These established players leverage their extensive distribution networks, long-standing clinical relationships, and broad product portfolios to secure large shares of global sales. Further, competition is driven by need for continuous technological innovation, evolving clinical requirements, and the growing importance of ease of use and patient safety. Companies compete not only on product performance and reliability but also on post-sales service, training programs, and clinical support for healthcare providers.
Companies with strong global distribution and localized support systems tend to perform better. Although price competition exists, especially in cost-sensitive regions, value-based differentiation often outweighs pure price considerations. Providers increasingly prefer solutions that offer long-term reliability, total lifecycle support, and lower overall cost of care.
Want to Explore More, Connect to our Analyst -
https://www.alliedmarketresearch.com/connect-to-analyst/A284556
Regional Outlook
By region, North America held the largest market share in the terms of revenue in 2023 and is likely to dominate the market during the forecast period. This is attributed to its advanced technology infrastructure, strong demand and availability of extracorporeal membrane oxygenation machine, and availability of well-developed healthcare facilities.
However, the Asia-Pacific region is expected to witness rapid industrialization. A surge in the geriatric population, increase in the prevalence of cardiac diseases, and increase in healthcare expenditure are expected to lead the growth of the market. Significant investments in healthcare infrastructure, especially in developing regions, are leading to the establishment of advanced critical care units equipped with extracorporeal membrane oxygenation machines, primarily serving adult patients.
Key Players
- Medtronic PLC
- Sorin Group
- Terumo Corporation
- MAQUET Holding
- Nipro Medical Corporation
- Microport Scientific Corporation
- Medos Medizintechnik AG
- Getinge AB
- Livanova PLC
- Fresnius Medical Care
Recent Developments
- In October 2021, Getinge launched the Rotaflow II extracorporeal life support system. The system, together with the Permanent Life Support (PLS) Set, offers up to 14 days of cardiopulmonary support in a compact, portable, safe, and reliable manner.
In summary, competition in the extracorporeal membrane oxygenation machine market is intense and defined by technological innovation, comprehensive service models, strong distribution networks, and proven clinical performance.
For Purchase Related Queries/Enquiry -
https://www.alliedmarketresearch.com/purchase-enquiry/A284556
How Do Government Policies and Regulations Impact Regional Market Growth?
Government policies and regulatory frameworks play an important role in shaping the growth of the extracorporeal membrane oxygenation machine market across different regions. Clear regulatory pathways, favorable reimbursement policies, and government healthcare investment significantly influence both market penetration and adoption rates. In North America, government support through streamlined regulatory approvals and reimbursement schemes encourages adoption of advanced critical care equipment like extracorporeal membrane oxygenation machine machines. In Europe, regulatory oversight is governed by the European Medical Device Regulation, which sets strict quality and safety standards for medical devices. In Asia-Pacific, policy initiatives around healthcare modernization and insurance coverage are expanding access to advanced therapies.
The report provides a detailed analysis of these key players in the global extracorporeal membrane oxygenation machine market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Explore AMR's Extensive Ongoing Coverage on Life Science Industry:
Rehabilitation Equipment Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031
HIV Drugs Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032
Nurse Call Systems Market: Global Opportunity Analysis and Industry Forecast, 2021-2030
Biobanking Market: Global Opportunity Analysis and Industry Forecast, 2021-2028
Medical Image Analysis Software Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031
Carrier Screening Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031
Elastography Imaging Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031
AVENUE - A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library on Avenue, designed specifically to offer cost-effective, one-stop solutions for enterprises, investors, and universities. With Avenue, subscribers can avail themselves of an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Us
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.
Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.
To find out more, visit www. Alliedmarketresearch.com or follow us on Twitter, LinkedIn and Facebook.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/extracorporeal-membrane-oxygenation-machine-ecmo-market-to-reach-793-7-million-globally-by-2033-at-4-6-cagr-allied-market-research-302694614.html
